Feb 28 (Reuters) - Creso Pharma Ltd (CPH) : FY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE A$32.8 MILLION VERSUS LOSS A$30.0 MILLION FY REVENUE FROM ORDINARY ACTIVITIES A$8.7 MILLION, UP 39.7%